INVO Fertility, Inc. (IVF)

Market Cap	2.72M -1.7%
Revenue (ttm)	7.53M +13.8%
Net Income	-8.76M
EPS	-8.34
Shares Out	4.77M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	86,606
Open	0.5300
Previous Close	0.5330
Day's Range	0.5292 - 0.5880
52-Week Range	0.5100 - 27.6000
Beta	1.44
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 16, 2026

About IVF

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2007
• Employees: 42
• Stock Exchange: Nasdaq
• Ticker Symbol: IVF
• Website: https://www.invofertility.com

Financial Performance

In 2025, INVO Fertility's revenue was $6.84 million, an increase of 4.73% compared to the previous year's $6.53 million. Losses were -$25.13 million, 164.3% more than in 2024.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 24, 2026

Data Sources Report a data error